Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06372184
NA

Washed Microbiota Transplantation for Allergic Rhinitis

Sponsor: The Second Hospital of Nanjing Medical University

View on ClinicalTrials.gov

Summary

Allergic rhinitis (AR) is characterized by sneezing, nasal congestion, nasal itching and nasal leakage and is caused by immunoglobulin E (IgE)-mediated reactions to inhaled allergens. Increasing evidence showed that gut microbiota could influence the development of AR, and we found that washed microbiota transplantation (WMT) could improve nasal symptoms in clinical practice. This clinical trial aims to evaluate the efficacy and safety of WMT for AR.

Official title: Efficacy and Safety of Washed Microbiota Transplantation for Allergic Rhinitis: A Randomized, Double-blind, Placebo-controlled Study

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2024-06-01

Completion Date

2029-10-01

Last Updated

2024-05-07

Healthy Volunteers

No

Interventions

DRUG

Washed Microbiota Transplantation

Patients take four capsules containing washed microbiota once a day for five consecutive days

DRUG

Placebo

Patients take four capsules in the same packaging as the experimental group once a day for five consecutive days

Locations (1)

Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China